GGO Vergunningendatabase

Zoekcriteria
Zoekresultaat
IM-MV 15-012_007 AMC Testing CTL019 in clinical trials with patients with B cell malignancies 26-02-2020 Vergunning verleend
IM-MV 16-004_008 AMC Testing the safety and efficacy of KTE-C19 in patients with refractory or relapsed B-cell malignancies 26-02-2020 Vergunning verleend
IM-MV 19-022_000 LUMC A phase II safety, dose finding and feasibility trial of MB-CART2019.1 in patients with relapsed or resistant B-NHL Vergunning verleend
IM-MV 19-024_000 Stichting Katholieke Universiteit EXPLORE: A Phase II, masked multicentre, randomised study to evaluate the safety and efficacy of two doses of GT005 administered as a single subretinal injection in subjects with geographic atrophy secondary to age-related macular degeneration Ontwerpbesluit genomen
IM-MV 20-001_000 UMCG Clinical testing of TX200-TR101, an autologous antigen-specific chimeric antigen receptor (CAR) T regulatory cell therapy. Ontwerpbesluit genomen